Search research articles
Contact Us
Filters
Showing results (901-910 of 934) with videos related to
Page
of 94
Sort By:
Journal of the American College of Cardiology
|
August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
American Heart Journal
|
June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
Orly Vardeny, Jacob A Udell, Jacob Joseph, et al.
JAMA
|
June 23, 2011
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
David Preiss, Sreenivasa Rao Kondapally Seshasai, Paul Welsh, et al.
JAMA
|
October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
American Heart Journal
|
December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction
Sean D Pokorney, Christina Radder, Phillip J Schulte, et al.
Circulation. Heart Failure
|
January 22, 2026
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial
Ayodele Odutayo, Deepak L Bhatt, Vikas S Sridhar, et al.
The American Journal of Geriatric Cardiology
|
June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly
Charles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
American Journal of Nephrology
|
December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Meg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.
Journal of the American College of Cardiology
|
February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial
Kenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 8, 2023
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
Tae Won Yi, Brendan Smyth, Gian Luca Di Tanna, et al.
Page
of 94
Search research articles
Search
Showing results (901-910 of 934) with videos related to
Sort By:
Page
of 94
Journal of the American College of Cardiology
|
August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
American Heart Journal
|
June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
Orly Vardeny, Jacob A Udell, Jacob Joseph, et al.
JAMA
|
June 23, 2011
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
David Preiss, Sreenivasa Rao Kondapally Seshasai, Paul Welsh, et al.
JAMA
|
October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
American Heart Journal
|
December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction
Sean D Pokorney, Christina Radder, Phillip J Schulte, et al.
Circulation. Heart Failure
|
January 22, 2026
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial
Ayodele Odutayo, Deepak L Bhatt, Vikas S Sridhar, et al.
The American Journal of Geriatric Cardiology
|
June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly
Charles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
American Journal of Nephrology
|
December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Meg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.
Journal of the American College of Cardiology
|
February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial
Kenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 8, 2023
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
Tae Won Yi, Brendan Smyth, Gian Luca Di Tanna, et al.
Page
of 94